en

Sign up
Investments involve risks and are not suitable for all investors.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Stock List・Iovance Biotherapeutics Inc
Search

Iovance Biotherapeutics Inc

Closed

Sector Healthcare

9.97 -4.41

Strong Buy

Price update 6 Sept 2024, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

9.75

Max

10.01

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+126.87 upside

Dividends

By Dow Jones

Next Earnings

5 Nov 2024

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

N/A / 10.315 Support & Resistance

Iovance Biotherapeutics Inc Chart

Related News

20 Feb 2024, 16:18 UTC

Major Market Movers

Iovance Shares Hits 52-Week High After Offering Pricing, FDA Approvals

DJ

Read

27 Dec 2023, 12:39 UTC

Major Market Movers

Iovance Shares Fall Premarket As FDA Places Study On Hold After Patient Death

DJ

Read

23 Mar 2024, 13:00 UTC

Top News

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

DJ

Read

Peer Comparison

Price change

Iovance Biotherapeutics Inc Forecast

Price Target

By TipRanks

126.87% upside

12 Months Forecast

Average 22.71 USD  126.87%

High 32 USD

Low 10 USD

Based on 9 Wall Street analysts offering 12 month price targets forIovance Biotherapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Based on 9 analysts giving stock ratings to Iovance Biotherapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

N/A / 10.315Support & Resistance

Short Term

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Very Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

Neutral Evidence

The bullish and bearish events are balanced.

Other stocks from the sector

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%